← FDA Drug Approvals (Drugs@FDA)

UCERIS

NDA · New Drug Application · Sponsor: SALIX · Approved 2014-10-07

Drug application

FDA Application #

NDA205613

Application type

New Drug Application

Brand name

UCERIS

Generic name

BUDESONIDE

Active ingredients

BUDESONIDE

Dosage form

AEROSOL, FOAM

Route

RECTAL

Marketing status

Prescription

Sponsor

SALIX

Manufacturer

Oceanside Pharmaceuticals

First approval

2014-10-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown